Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants: An Evidence-Based Approach

(2019) Erik A Jensen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children’s hospitals

(2019) Nicolas A. Bamat et al.   Journal of Perinatology

Respiratory medication use in extremely premature (

(2019) James M. Greenberg et al.   PEDIATRIC PULMONOLOGY

Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants

(2018) Rachel G. Greenberg et al.   JOURNAL OF PEDIATRICS

Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure

(2017) Veena S. Rao et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Medication Use in the Neonatal Intensive Care Unit

(2013) Emily Hsieh et al.   AMERICAN JOURNAL OF PERINATOLOGY

Variation in the Use of Diuretic Therapy for Infants With Bronchopulmonary Dysplasia

(2013) J. L. Slaughter et al.   PEDIATRICS

Diuretics for very low birth weight infants in the first 28 days: a survey of the US neonatologists

(2011) J I Hagadorn et al.   Journal of Perinatology

Unwarranted Variation in Pediatric Medical Care

(2009) David C. Goodman   PEDIATRIC CLINICS OF NORTH AMERICA

Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants

(2009) Charlotte Gimpel et al.   PEDIATRICS INTERNATIONAL